Planning for Outcomes (P


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
06 2019
Historique:
received: 06 02 2019
accepted: 07 05 2019
pubmed: 14 6 2019
medline: 6 2 2020
entrez: 14 6 2019
Statut: epublish

Résumé

Observational studies raise concern about a potential link between injectable progestin contraceptive use and HIV acquisition risk. This possible link is particularly relevant in sub-Saharan Africa where HIV risk is high and the method mix is skewed toward injectables. We developed the Planning for Outcomes (P P Illustrative results from all sub-Saharan African countries combined and from selected countries demonstrate the potential of P Policy makers and program planners may use P

Sections du résumé

BACKGROUND
Observational studies raise concern about a potential link between injectable progestin contraceptive use and HIV acquisition risk. This possible link is particularly relevant in sub-Saharan Africa where HIV risk is high and the method mix is skewed toward injectables. We developed the Planning for Outcomes (P
METHODS
P
RESULTS
Illustrative results from all sub-Saharan African countries combined and from selected countries demonstrate the potential of P
CONCLUSIONS
Policy makers and program planners may use P

Identifiants

pubmed: 31189699
pii: GHSP-D-19-00062
doi: 10.9745/GHSP-D-19-00062
pmc: PMC6641814
doi:

Substances chimiques

Contraceptive Agents, Female 0
Progestins 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

317-328

Informations de copyright

© Lebetkin et al.

Références

J Infect Dis. 2018 Jun 5;218(1):16-25
pubmed: 29514254
AIDS. 2016 Nov 13;30(17):2665-2683
pubmed: 27500670
Contraception. 2019 Apr;99(4):199-204
pubmed: 30576636
Glob Health Sci Pract. 2017 Dec 28;5(4):581-591
pubmed: 29284696
Int Perspect Sex Reprod Health. 2014 Sep;40(3):144-53
pubmed: 25271650
Glob Health Sci Pract. 2013 Jul 26;1(2):203-12
pubmed: 25276533
Gates Open Res. 2017 Dec 29;1:17
pubmed: 29355224
AIDS. 2013 Jan 2;27(1):105-113
pubmed: 23014519
Contraception. 2012 Dec;86(6):645-52
pubmed: 22541635
Bull World Health Organ. 2012 Aug 1;90(8):595-603
pubmed: 22893743

Auteurs

Elena Lebetkin (E)

FHI 360, Durham, NC, USA. elebetkin@fhi360.org.

Xiaoming Gao (X)

FHI 360, Durham, NC, USA.

Douglas Taylor (D)

FHI 360, Durham, NC, USA.

Lauren Y Maldonado (LY)

FHI 360, Durham, NC, USA.

Abdulmumin Saad (A)

United States Agency for International Development, Washington, DC, USA.

Markus J Steiner (MJ)

FHI 360, Durham, NC, USA.

Laneta J Dorflinger (LJ)

FHI 360, Durham, NC, USA.

Kavita Nanda (K)

FHI 360, Durham, NC, USA.

Timothy D Mastro (TD)

FHI 360, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH